Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 115,011 $ (103,721) $ 11,290
Beginning balance, shares at Dec. 31, 2020 1,613,591      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 3,295      
Issuance of common stock for board of directors’ compensation 272 272
Issuance of common stock for board of directors' compensation, shares 8,677      
Share-based compensation 919 919
Net loss (4,649) (4,649)
Issuance of common shares upon exercise of warrants, net of financing costs 11,593 11,593
Issuance of common shares upon exercise of warrants, net of financing costs, shares 713,362      
Ending balance, value at Mar. 31, 2021 127,795 (108,370) 19,425
Ending balance, shares at Mar. 31, 2021 2,338,925      
Beginning balance, value at Dec. 31, 2020 115,011 (103,721) 11,290
Beginning balance, shares at Dec. 31, 2020 1,613,591      
Net loss       (9,391)
Ending balance, value at Jun. 30, 2021 130,703 (113,112) 17,591
Ending balance, shares at Jun. 30, 2021 2,412,032      
Beginning balance, value at Mar. 31, 2021 127,795 (108,370) 19,425
Beginning balance, shares at Mar. 31, 2021 2,338,925      
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs 1,826 1,826
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs, shares 67,043      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 2,654      
Issuance of common stock for board of directors’ compensation 19 19
Issuance of common stock for board of directors' compensation, shares 910      
Share-based compensation 1,010 1,010
Net loss (4,742) (4,742)
Issuance of common stock to consultants 53 53
Issuance of common stock to consultants, shares 2,500      
Ending balance, value at Jun. 30, 2021 130,703 (113,112) 17,591
Ending balance, shares at Jun. 30, 2021 2,412,032      
Beginning balance, value at Dec. 31, 2021 132,411 (122,754) 9,657 [1]
Beginning balance, shares at Dec. 31, 2021 2,416,021      
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs 3,004 3,004
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs, shares 298,761      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 13,721      
Issuance of common stock for board of directors’ compensation 235 235
Issuance of common stock for board of directors' compensation, shares 24,458      
Share-based compensation 521 521
Net loss (4,811) (4,811)
Ending balance, value at Mar. 31, 2022 136,171 (127,565) 8,606
Ending balance, shares at Mar. 31, 2022 2,752,961      
Beginning balance, value at Dec. 31, 2021 132,411 (122,754) 9,657 [1]
Beginning balance, shares at Dec. 31, 2021 2,416,021      
Net loss       (9,951)
Ending balance, value at Jun. 30, 2022 136,677 (132,705) 3,972
Ending balance, shares at Jun. 30, 2022 2,765,259      
Beginning balance, value at Mar. 31, 2022 136,171 (127,565) 8,606
Beginning balance, shares at Mar. 31, 2022 2,752,961      
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs 45 45
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs, shares 8,124      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 4,174      
Share-based compensation 461 461
Net loss (5,140) (5,140)
Ending balance, value at Jun. 30, 2022 $ 136,677 $ (132,705) $ 3,972
Ending balance, shares at Jun. 30, 2022 2,765,259      
[1] Derived from audited consolidated financial statements